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Bio-interface of conducting polymer-based materials for neuroregeneration
Abstract
Nerve system diseases like Parkinson's disease, Huntington's disease, Alzheimer's disease, etc. seriously
affect thousands of patients' lives every year, making them suffer from pains and inconvenience. Recently,
bio-interfaces between neural cells/tissues and polymer based biomaterials attracted worldwide attention
due to the ability of polymer based biomaterials to serve as nerve conduits, drug carriers and neurites
guidance platform in neuroregeneration. The role that bio-interface played and the way it interacted with
neural tissues and cells have been thoroughly investigated by the researchers. In this paper we mainly
focus on reviewing the bio-interface between nerve tissues/cells and advanced functional biocompatible
polymers, such as conducting polymers and advanced carbon composite materials. These advanced
polymers can provide combined interfacial stimulations including interfacial external neurotrophic factors
(NTFs) delivery, electrical stimulation, surface guidance and molecules decoration to lesion cells and
tissues to promote neuroregeneration in vitro and in vivo, and have contributed greatly to nerve diseases
therapy. At the end of this review, the criteria of polymer based biomaterials utilized in neuroregeneration
are summarized and the perspectives for future development of bio-interfaces are also discussed.
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Nerve system diseases like Parkinson’s disease, Huntington's disease and Alzheimer's disease
etc. seriously affect thousands of patients’ lives every year, making the patients suffer from
pains and inconvenience brought about by these diseases. Recently, bio-interface between
neural cells/tissues and polymer based biomaterials attracted worldwide attention due to the
ability of polymer based biomaterials to serve as nerve conduits, drug carrier and neurites
guidance platform in neuroregeneration. The role that bio-interface played and the way it
interacted with neural tissues and cells have been thoroughly investigated by the researchers.
In this paper we mainly focus on reviewing bio-interface between nerve tissues/cells and
advanced functional biocompatible polymers, such as conducting polymers and advanced
carbon composites materials.. These advanced polymers can provide combined interfacial
stimulations including interfacial NTFs delivery, electrical stimulation, surface guidance and
molecules decoration to lesion cells and tissues to promote neuroregeneration in vitro and in
vivo, and have contributed greatly to nerve diseases therapy. At the end of this review, the
criteria of polymer based biomaterials utilized in neuroregeneration are summarized and the
perspectives for future development of bio-interfaces are also discussed.
1. Introduction
1

The nerve system is a complex and sophisticated system that regulates and coordinates body
activities. The nerve system is vulnerable to various external and internal influences and can
be damaged by multiple reasons, such as trauma, infection, degeneration, blood flow
disruption and autoimmune disorders[1]. These damages may cause serious nerve system
diseases, such as spinal cord injury, Parkinson’s disease (PD)[2], Huntington's disease (HD)[3]
and Alzheimer's disease(AD)[4] etc., which affect thousands of peoples’ lives every year and
bring deep sufferings to human beings.
The therapies for these diseases attracted a broad range of attention worldwide from local
communities to the research industry as they are expected to relieve the patients’ suffering to
some extent. The nerve system diseases currently can be treated in hospital by doctors in
neurology, neurological surgery and rehabilitation department via medicine, surgery and
physical methods for nerve system recovery. Meanwhile, huge attention has been paid by
global researchers on more effective neuroregeneration methods to enhance nerve system
diseases therapy[5].
To understand the importance of neuroregeneration, the pathogenesis of neural diseases and
how neuroregeneration approaches influence neural tissues/cells should be discussed. The
neural system is constituted of two major parts, the central nervous system (CNS) which
consists of the spinal cord and brain, and the peripheral nervous system (PNS) which consists of
all other neural elements according to their different functions [6]. Most neural system diseases
are caused by damages to the CNS, including spinal cord injury (SCI) and brain damage.
Spinal cord injury is a major cause of disability. The functional decline of SCI is contributed
to by both direct mechanical injury and secondary pathophysiological mechanisms that are
induced by the initial trauma. These mechanisms initially involve widespread haemorrhage at
the site of injury and necrosis of the central nervous system (CNS) cellular components. At
later stages of injury, the cord is observed to display reactive gliosis. The actions of astrocytes
as well as numerous other cells in this response create an environment that is highly
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nonpermissive to axonal regrowth. This affects the communication between the PNS and the
brain and finally leads to disability [7].
Meanwhile, damage to the brain, including neurotropic viral infections, stroke, paraneoplastic
disorders, traumatic brain injury and multiple sclerosis[8], which can trigger slow and
progressive dysfunction and loss of neurons and axons in the CNS, is the primary pathological
feature of acute and chronic neurodegenerative conditions such as AD, PD and HD. For
example, in Alzheimer’s disease, characteristic dementia is attributed to widespread
degeneration of cerebral cortical neurons and secondary cholinergic differentiation; in
Parkinson’s disease, the classic hypokinetic movement disorder seems to result from loss of
modulatory dopaminergic input to the striatum from the substantia nigra; and in Huntington’s
disease, loss of striatal output neurons leads to the motor, cognitive, and affective
abnormalities that are characteristic of this disease [9].
Evidence suggests that the brain, like many other tissues, is in a state of dynamic equilibrium.
It has an endogenous population of neuronblast that proliferate in response to environmental
and pharmacological manipulations and that can replace cells lost in some experimental
lesions

[10]

. The adult rodent brain generates neuronal progenitor cells in the subventricular

zone (SVZ) and in the dentate gyrus of the hippocampus throughout life. The persistence of
neurogenesis in the adult mammalian brain suggests that endogenous precursors are a source
for neuronal replacement after brain injury. After stroke in the adult brain, the neuroblast
population is greatly expanded in the SVZ, and these cells are recruited to areas bordering the
infarct, where they can differentiate into neurons and thereby replace lost neurons[11].
Although the expansion of neuroblast population may help to promote the neuroregenerative
process, the fact remains that neurodegenerative disorders such as AD, PD and HD are
characterized by continuous loss of neurons that are not replaced, which means that a primary
deficit in neural stem-cell proliferation; migration, or differentiation, or both, might contribute
to net cell loss and neuronal circuit disruption in these disorders. This claim, supported by
3

work with animals, proposes that failure of endogenous neural stem cells to respond
appropriately and replace neurons lost to neurodegenerative disease might be a further
common mechanism that contributes to functional compromise[12]. Therefore, promoting
neuroregeneration via multiple approaches, such as stimulating neurogenesis, to generate
regenerative neurons to replace lesion neurons and axons can be a common method for neural
system diseases treatments.
Neuroregeneration, as a fast growing area dedicated to new methods to recover nerve
functionality after injury in treatment, refers to the regrowth or reconstruction of nerve cells,
tissues or cell products via multiple stimulation methods to nerve cells or tissues[10].
Polymers have controllable interfacial, physical and chemical properties, micro- and nanoprocessable abilities, as well as tunable conductivities to make them ideal platform materials
for neuroregeneration[13]. The development of advanced biocompatible polymers afforded
more possibilities in neuroregeneration by offering multiple interfacial stimulations for
neuroregeneration, including providing external neurotrophic factors (NTFs) to the nerve
injury site directly or by novel cyto-compatible scaffolds to stimulate cells biologically[14-17],
using nerve conduits at lesion gaps as templates to guide nerve neurites growth and
stimulating cells via various cues such as topographical cues[18-21], electrical cues[22] and
physical cues[23-25]. The realization of these stimulations is more determined by the surface
properties of the polymers and the interactions between cells/tissues and polymer surfaces
rather than the bulk properties of biopolymers.
Polymers can provide interfacial stimulations to nerve cells/tissues in the following ways: 1)
Interfacial NTFs delivery: biodegradable polymers (poly(DL-lactide)co-glycolide (PLGA)[14,
15]

, poly(ε-caprolactone) (PCL)[16], polyL-lactic

acid (PLLA)[17]etc.) are ideal platforms

materials for interfacial delivery of NTFs to abnormal tissues in various neural disease
treatments; 2) Interfacial surface guidance: processable biopolymers can be fabricated into
aligned

structures

at

different

scales,

including
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nanofibers[26-28],

microfibers[18,19],

microlines[20,21] and micro-tunnels[29,30], to influence interfacial interactions between neural
cells/tissues and surfaces; 3) Interfacial electrical stimulation (ES): ES could be applied on the
surface of nerve cells via biocompatible conducting polymers (CPs) platforms to enhance
nerve cell proliferation and neurites outgrowth[22]; 4) Interfacial molecules decoration:
multiple biomolecules and proteins can be decorated onto the surfaces of polymer scaffolds
to improve the adhesion and growth of nerve cells[31]; 5) Combined interfacial stimulations:
recent research revealed that the combinations of these stimulation methods can further
improve the interfacial interactions between lesion cells/tissues and polymer based
biomaterials, as well as the effects of nerve diseases treatments [29, 32].
The studies of using polymers in neuroregeneration started from traditional biopolymers, such
as PLGA[29,33], polyglycolic acid (PGA)[34], polylactic acid (PLA)[35] etc, due to their ability to
provide interfacial NTFs delivery to lesion nerve tissue/cells and their biocompatibility.
However, this simple and monotonous stimulation method cannot fulfil the developing
requirements for multiple and combined stimulations in neuroregeneration. CPs, as possible
candidates to resolve this question, were investigated widely in this area as platform materials
for neuroregeneration. Firstly, CPs are conductive and thus can provide interfacial ES to nerve
tissue/cells seeded on them. Secondly, CPs can provide controlled interfacial NTFs delivery
by incorporating NTFs as dopants in polymer chains to realize a controllable long-term
interfacial NTFs delivery. In addition, other biomolecules for cell adhesion or further
modification can also be incorporated into CPs as dopants. Moreover, most CPs are
processable and thus can be fabricated into various structures, including microtubes,
microlines, microfibers and nanofibers, to provide interfacial surface guidance to neuron
tissues/cells. Therefore, CPs can be considered as the most suitable platform materials for
their ability to combine multiple interfacial stimulations.

5

In this paper all kinds of stimulations that traditional polymers and CPs can provide will be
reviewed and compared for their advantages and disadvantages. Bio-interface effects of
traditional synthetic and natural biodegradable polymers, e.g. PLGA, PLA, chitosan, would be
only briefly reviewed for their limitations discussed above. The most recent progress of the
applications of functional materials (CPs, carbon nanotubes (CNTs), graphene, etc.) in
neuroregeneration and their interfacial properties will be focused upon and reviewed in detail.
The criteria and prospectivity of the bio-interface of polymer based biomaterials will also be
discussed.
2. Bio-interface of traditional Biopolymers in Neuroregeneration
The earliest utilization of polymers in neuroregeneration was aroused by the increasing needs
for delivering NTFs and guiding neurites growth at lesion site in nerve disease therapy.
PLGA, a synthetic biodegradable polymer, which was used as a drug carrier in other disease
treatments[36,

37]

, was firstly introduced by Camarata et al. to neuroregeneration.

Biodegradable PLGA microspheres were used to deliver nerve growth factor (NGF) in both in
vitro and in vivo experiments to nerve cells and brain tissues [14]. NGF can be released to a
lesion site over a relatively long period with the degradation of PLGA. Results demonstrated
that NGF loaded PLGA microspheres showed a continuous release into both cell culture
medium and rat brain over a prolonged period of time and led to neurite outgrowth. This
material is processable and the release period of NTFs can vary from weeks to years by
controlling the preparation conditions and the ratio of lactide and glycolide in the polymer
chains [38].
PLGA, together with polymers with similar structures (PLA, PGA), have been studied over a
relatively long period and been verified as bio-safe in both in vivo and in vitro experiments,
and have already been approved by the Food and Drugs Administration (FDA) for
commercial use in clinical applications [39]. Most of these materials are soluble and can be
formed into multi-scale morphologies, e.g. microspheres and micro-tunnels, to provide
6

interfacial support to neural cells/tissues while providing NTFs. Also, natural biodegradable
polymers including chitosan and alginate can perform similar functions and work
independently or together with synthetic polymers as drug delivery platforms or nerve
conduits.
Although the advantages of these traditional biopolymers are quite apparent, disadvantages of
these synthetic polymers cannot be neglected either. The first disadvantage of synthetic
biodegradable polymers is that the incorporation efficiency of proteins is low because of the
degradation of NTFs due to the harsh synthetic conditions. In addition, PLGA and most other
synthetic biodegradable polymers, such as PLLA, PCL, poly (hydroxybu- tyrate) (PHB)

[40]

etc., are hydrophobic, which limits their use in tissue engineering due to their poor cell
adhesion abilities.
To overcome these harsh synthetic conditions and cell adhesion issues, some water soluble
and hydrophilic natural biodegradable polymers, such as chitosan [29, 41], collagen and alginate
etc. [35], were introduced into neuroregeneration to provide a similar interfacial NTFs delivery
service as PLGA. In comparison with synthetic polymers like PLGA, these polymers can be
prepared under more gentle conditions from aqueous solutions, which are extraordinarily
beneficial to keep the bioactivities of NTFs proteins. However, the interfacial NTFs delivery
provided by natural biopolymers (Chitosan, Collagen) is not as controllable as synthetic
polymers (PLGA, PLLA, PLA). When used in NTFs delivery, there often occurred a burst
release in the initial several hours during the release period, thus it is hard to maintain a long
period sustainable protein release.
Therefore, a series of composites and structures were designed to combine the advantages of
both types of biopolymers with enhanced interfacial properties, cell adhesion ability and
NTFs delivery ability to promote neurites’ surface interaction with NCs for clinical translation
[35, 42]

. Hyaluronic acid (HA) is a natural biopolymer which showed distinct advantages for

neural repair by preventing glial scar formation, inducing endogenous neurons migration in
7

the gel

[30]

. To introduce interfacial NTFs delivery ability into a HA scaffold, PLGA

microspheres loaded with brain-derived neurotrophic factors (BDNF) and vascular endothelial
growth factors (VEGF) were incorporated into the HA scaffold to mimic the in vivo
environment in nerve repair[29]. Experimental results showed that the hydrogel composite
containing BDNF and VEGF shows a significant effect on neural stem cells (NSCs)
proliferation in comparison with particle-free HA scaffold (Figure 1).
Besides composite materials, special structures were also designed to promote interfacial
neurites guidance together with NTFs delivery. The most often used structure in
neuroregeneration made from traditional biopolymers were nerve conduits (NCs). NCs are
tubular structures that are used to bridge the gap of a severed nerve, by acting as a guide for
the regenerating neurites and as a barrier against the ingrowth of scar-forming tissue (Figure
2). Polymer NCs have been made of various materials of biologic (vein, alginate and
chitosan) or synthetic origin (PLGA, PLA, silicone and poly(hydroxbutyrate)), as reviewed in
several publications

[43-46]

. Depending on the material, NCs can be commonly produced by

melt extrusion, dip coating, casting, or depositing material on a rotating mandrel. Typical NC
dimensions for experimental use in small animals are inner diameters of 1–2 mm and lengths
of several millimetres, depending on the experimental gap length

[47]

. The most often studied

polymer NCs have been reviewed in a paper published by Pfister etc. [44] (Table 1).
Madduri etc. fabricated thermal cross-linked collagen NCs by using spinning mandrel
technology loaded with glial cell line-derived neurotrophic factor (GDNF) and NGF (Figure
2). NCs were coated with several layers of PLGA after fabrication. The release of the
neurotrophic factors was sustained for over 30 days and remained biologically active, as
confirmed by an in vitro bioassay using chicken embryonic dorsal root ganglion (DRG)
explants[53].This method protected the bioactivity of NTFs by trapping NTF proteins in
collagen and preventing fast release of NTFs by coating a PLGA layer outside.
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PLGA NCs filled with collagen sponge successfully provided adequate scaffolding for nerve
tissue extension to serve as a connective guide across a 15mm gap in the left peroneal nerve
(Figure 3). In comparison with autografting, this composite nerve conduit enabled superior
functional recovery and shortened recovery period [54].
In summary, the employment of traditional polymers, including synthetic polymers (PLGA,
PLLA, PLA) and natural biopolymers (chitosan, collagen, HA), successfully achieved the
target of providing effective interfacial NTFs delivery to severed nerves in neuroregeneration.
In addition, special NCs structures made from these polymers can also provide interfacial
guidance at lesion gaps for nerve functional recovery. However, traditional polymers cannot
provide interfacial ES to nerve tissues/cells due to their being insulators. Another limitation of
traditional polymers is that NTFs contained in these polymers were passively released with
time. The release period may be adjusted by the structure of the polymer, but a more accurate
“release on demand” system cannot be created based on these polymers. The relatively simple
and monotonous chemical structures made further surface modification very difficult too.
More complicated systems that can provide combined interfacial stimulations were strongly
needed to enhance neuroregeneration efficiency.
3. Bio-interface of CPs in Neuroregeneration
An electrophysiology study in the late nineteenth century suggested that neurons in the nerve
system transferred information through bioelectrical signals

[55]

. Since then, the influence of

external ES on the nerve system has been investigated in a series of studies[56] in the midtwentieth century and it has been proven that electrical charges play an important role in
stimulating either the proliferation or differentiation of various cell types [57]. Also extensive
research both in vitro and in vivo has shown that electromagnetic fields play an important role
in neurite extension and regeneration of transected nerve ends [58].
These findings led researchers to think about introducing conductive platform materials to
neuroregeneration in order to provide interfacial ES directly to nerve tissues/cells instead of
9

external stimulation in cell/tissue culture medium[58]. In addition, a conductive scaffold is
more suitable for implantation to provide ES in vivo from a clinical perspective.
These conductive platform materials could be semi-conductors such as silicon, metals and
CPs. In comparison with other conductive or semi-conductive platforms (metal, silicon), CPs
showed their specific advantages in neuroregeneration. CPs were softer and more stretchable
than metal or silicon[59], which can not only promote cell adhesion on their surfaces, but can
also be beneficial for the implantation device. Also, CPs demonstrated low impedence and
recorded better signals compared to metal, and thus were often used as the modification layer
in nerve probe applications[60]. In addition, their semi-conductive property helped CPs
platforms to avoid exorbitant current stimulation that may kill nerve tissues/cells[58]. The
needs in neuroregeneration for conductive platforms and the merits that CPs had over other
candidates made CPs to be chosen by researchers for investigations as platform materials in
neuroregeneration.
3.1. CPs
Until about 30 years ago, all carbon based polymers were rigidly regarded as insulators. In
1977, it was found that polyacetylene could be rendered conductive by doping [61]. Since then,
a series of conductive polymers, including polyaniline (PANi), polypyrrole (PPy) and
polythiophenes such as poly(3,4-ethylenedioxythiophene) (PEDOT) (Figure 4), have been
widely investigated and applied in various areas including neuroregeneration.
CPs are organic polymers that can conduct electricity due to the π–π coupling structure in the
polymer chains. Charges can transfer through these specific conjugated structures and showed
comparable conductivity to semiconductors. The interfacial, physical, chemical, and
electrochemical properties (conductivity and impedance) of CPs can be fine-tuned by
synthesizing polymers under different polymerization conditions. In addition, CPs also
exhibited electrochemical activity and redox properties when doped with various ions.
Furthermore, most CPs are soluble and processable, and thus can be fabricated into different
10

topographies and patterns with enhanced interfacial properties to serve as tissue engineering
scaffolds.
3.2. Compatibility of CPs
Biocompatibility is the key issue which determines whether a material can serve in tissue
engineering or not. The in vitro and in vivo compatibility of CPs has already been proven by
researchers in a series of experiments. For example, a study on PPy in nerve tissue
engineering utilizes electrochemically synthesized PPy films to evaluate the biocompatibility
of materials [62]. Experimental results demonstrated that PPy can support the adhesion and
growth of L929 mouse fibroblast and neuro2a neuroblastoma cells in vitro. In an in vivo
experiment, there was only a minimal tissue response after PPy was implanted into a rat
model for 4 weeks. Studies also demonstrated that PPy is compatible with nerve cell and
tissue when applying ES, [22, 62] although some evidence of toxicity was reported after long
term large current stimulation (e.g. 1mA, 96h [62]). Also, some evidences showed PANi is
compatible in vitro to several cell lines including PC 12 and H9c2 cardiac myoblasts [63] and
in vivo after implantation [64].
3.3. Interfacial ES of CPs in Neuroregeneration
After being verified as biocompatible, PPy was firstly reported by the C.E Schimidt group in
an application as a neuroregeneration scaffold in 1997[22]. In Schimidt’s study, PPy film was
electrochemically coated on ITO glass and used as substrates for PC 12 cell culture. PC 12
cells attached and extended well on PPy films in comparison with PLA and PLGA. The
conductivity of the film was detected to be ~ 10 S/cm. A 100 mV potential was applied to PPy
films for nerve cell stimulation in vitro to study the influence of ES on neurite extension.
Results showed that PC 12 cells cultured on PPy films and subjected to ES through the film
underwent a significant increase in neurite lengths compared to the ones that were not
subjected to ES through the film (Figure 5). The median neurite length for PC 12 cells grown
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on PPy and subjected to an electrical stimulus was 18.14 μm (n = 5643) compared with 9.5
μm (n = 4440) for controls.
Since then, a series of approaches have been developed to enhance nerve regeneration
efficiency of CPs by combining electrical, biological and topographical stimulations together
in one scaffold to promote the interaction between scaffold and neural cells/tissues.
3.4. Interfacial molecules decoration of CPs in Neuroregeneration
To improve the surface interaction between CPs and nerve tissues/cells and enhance
neuroregeneration efficiency, a series of biomolecules were decorated on CPs’ polymer
chains to tune the physical, chemical and interfacial properties of CPs. For example, the
incorporation of NTFs can promote neurons proliferations and axons extension while the
modification of other proteins (collagen, laminin etc.) can help to improve cell adhesion
properties. Furthermore, some other dopant molecules, such as CS, HA, heparin dextran
sulphate, can adjust hardness, roughness, modulus of CPs for further implantation in vivo. In
addition, the combined utilization of these biomolecules in CPs became a trend in most recent
research work.
3.4.1. Incorporation of NTFs into CPs
3.4.1.1. Entrapment of NTFs in CPs via Electrical Deposition
The most typical method of incorporating NTFs in CPs is the entrapment method. NTFs and
monomers were mixed together in solution with supporting dopants and then followed by
electrochemical deposition on a conductive substrate. NTFs were trapped in CPs film during
this procedure. When ES was applied, a redox reaction occurred on the CPs films which led to
the release of NTFs with dopants into the environment.
The G. G. Wallace group firstly studied the possibility of incorporation of neurotrophin-3
(NT-3) into PPy film using an electrical deposition method in 2006. The loading capacity and
amount of NT-3 released from the polymer was determined using

125

I-labelled NT-3 under

various electrochemical conditions. Electrochemical stimulation of PPy by pulsed voltage,
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pulsed current and CV all promoted the release rate of NT-3 compared to passive release of
NT-3 unstimulated. NT-3 was released from PPy as an initial burst in the first 24 h followed
by prolonged release over 6 days. The amount of NT-3 incorporated into the polymer was
determined by the film thickness and polymerization time, with longer growth periods
incorporating more NT-3[65].
This method has been employed in a number of studies in nerve tissue engineering
applications to be proven as an effective method to deliver NTFs to nerve cells. Richardson et
al. used this kind of electrodeposited PPy/tosylate(pTS)/NT-3 platform in Cochlear implants
(pTS as supporting dopant), and showed that neurites outgrowth from auditory neurons (spiral
ganglion neurons (SGNs)) grown on this platform is longer than that cultured on a PPy/pTS
platform, which was equivalent to tissue culture plastic (passive control). ES of PPy/pTS/NT3 with a biphasic current pulse, as used in Cochlear implants, significantly improved neurite
outgrowth from explants. That means this scaffold can provide a biocompatible, lowimpedance substrate for storage and release of NT-3 to help to protect auditory neurons if
applied to the Cochlear implant, and will enhance neurite outgrowth [66]. A similar work using
BDNF instead of NT-3 with the same protocol achieved a similar conclusion as above [67].
This PPy/pTS/NT-3 system has also been coated on platinum Cochlear implant electrodes for
in vivo study. When implanted into deafened cochleae, stimulated PPy/pTS/NT-3 coated
electrodes promoted a slight improvement to neural density, without affecting fibrous tissue
formation [68].
Thompson et al. then further investigated the effect of dual neurotrophins using BDNF and
NT-3 on this platform. Neurite outgrowth from Cochlear neural explants grown on polymers
containing both NT-3 and BDNF showed significant improvement over PPy doped only with
NT-3 or BDNF, due to the synergistic effect of both neurotrophins. Neurite outgrowth was
further improved when ES was applied on dual neurotrophins incorporated scaffold (Figure
6) [69].
13

The following study by Thompson et al. showed that dopant anions were of great importance
to the electrical deposited PPy/dopant/NTFs platform in their influence on the properties of
PPy film and release kinetics. Different dopants, sodium salts of pTS, dodecyl
benzenesulfonate (DBS), poly(styrenesulfonate) (PSS), HA and chondroitin sulfate (CS) and
the ammonium salt of PMAS, were used in the synthesis of PPy with NT-3 to investigate this
influence, and the results illustrated that the physical properties (roughness, conductivity) of
PPy films and kinetics of NT-3 release were both affected by dopants. That is possibly due to
the difference in surface area or electrochemical properties of PPy films which were caused
by the size and properties of different dopant molecules. Surprisingly, PPy films doped with
the smallest dopants (pTS and DBS) were found to have the best conductivity and
biocompatibility with the neural tissue cultured, and demonstrated the best release kinetics as
well as neurite outgrowth performance. Instead, natural biomolecule dopants, such as HA and
CS, did not show any advantage in biocompatibility as assumed [70].
Kim et al. (D. Martin group) used this method to synthesize PPy/NGF and PEDOT/NGF films
for a PC 12 cells study. Optical and fluorescence microscopy revealed that PC 12 (rat
pheochromacytoma) cells can well adhere to and have extended neurites on both NGFmodified substrates, indicating that the NGF in the polymer film is biologically active. In
addition, electrochemical properties study revealed that the NGF-modified CPs substrates
both showed very low minimum impedance [71].
The entrapment of NTFs in CPs via electrical deposition achieved successful interfacial NTFs
delivery with little passive release and created visible improvement on nerve cell proliferation
and neurites extension. But it needs a high concentration of NTFs during electrochemical
deposition to ensure that there were enough NTFs trapped in CPs films. The progressively
passive release of NTFs into the medium may decrease the bioactivity of NTFs. Tissues/cells
cannot survive long without additional NTFs supply.
3.4.1.2. Chemical NTFs Modification on CPs Surface
14

To avoid the passive release of NTFs and the lost of bioactivity of NTFs, another strategy to
chemically modify the NTFs on CPs surface via chemical reactions was developed. Through
NTFs incorporation, it was expected that NTFs can be delivered exactly to the injury sites,
and nerve cell neurite outgrowth and network formation can be enhanced without any external
NTFs addition via this method[65].
Chemical modification of NTFs on CPs scaffold surfaces can be carried out with either
selected dopants that copolymerize with CPs or modified CPs monomers, even via some
specific intermediate molecule. NTFs anchored on CPs through chemical modification were
connected covalently to the scaffold surface and were hardly released from the CPs scaffold
without ES. NTFs chemically modified on CPs can remain bioactive over a relatively long
period, thus it avoids NTFs wastage during both the modification procedure and cell culture
experiments.
Biotin, which is also known as vitamin B7 or coenzyme R, is a popular intermediate molecule
used in controlled drug release. Langer et al. used Biotin as dopant in PPy
electropolymerization, and then incubated Biotin-doped PPy films with streptavidin to form a
surface capable of attaching any biotin labeled compound. The stability of biotin-doped PPy
was tested by storing the sample in PBS for 14 days. Results showed that there was no release
of biotin without activation. Modified biotinylated NGF can bind to the streptavidin and be
released via ES together with biotin. The stimulated released NGF remained active and
caused PC 12 neurite outgrowth with no statistical difference when compared to unreleased
NGF anchored on biotin-doped PPy film and unmodified NGF directly added to cell culture
medium[72].
C. E. Schmidt group immobilized NGF on the surface of PPy film surface using an
intermediate linker provided by a layer of polyallylamine conjugated to an arylazido
functional group [73]. NGF was fixed to the substrate upon exposure to UV light and activation
of the azido groups (Figure 7). The immobilization of 0.98ng/mm2 NGF on PPy surface
15

produced similar neurite extension in PC12 cells compared to soluble NGF 50ng/mL. In
addition, ES using PPy NGF further increased neurite length by 50% with respect to controls
without stimulation. Cell adhesion was also improved as a consequence of the immobilization
procedure. This suggested a possible method to enhance both electrical and biological
stimulation to nerve cells. The only disadvantage of this method is the decrease in
conductivity of PPy (10-3 – 10-6 S/cm) in comparison with original PPy (10 S/cm) which may
affect the stability of the PPy NGF film for long term ES.
To overcome this disadvantage, the Schmidt group developed copolymers of N-hydroxyl
succinimidyl ester pyrrole (PPy/NSE) and regular pyrrole, which can be immobilized with
NGF without significantly hindering conductivity (Figure 8). A copolymer containing 50:50
monomer ratio of pyrrole/pyrrole-NSE was electrochemically deposited and selected for
further NGF modification for its good conductivity (~8S/cm) and active ester groups for NGF
immobilization. The active ester groups were stable for up to 5 days. Application of an
external electrical potential to NGF immobilized PPy films did not cause a significant release
of NGF nor reduce their neurotrophic activity [74].
Chemically modified NTFs on a CPs surface showed better controllable ability (less passive
release, NTFs not consumed) with regards to entrapped NTFs by electrical deposition.
However, the chemical modification procedure is more complex and normally needs more
than one step to achieve final products. It is time and efforts consuming. Furthermore,
chemical modification also needs specific/non-general chemical reactions on both CPs and
NTFs, even the monomer had to be specifically designed, which is not suitable for clinical
usage that needs massive amounts of commercial products.
3.4.2. Incorporation of Cell Adhesion Proteins in CPs
Physical adsorption of cell adhesion biomolecules is the most often used method in CPs tissue
engineering work and is performed by dipping the CPs scaffold in cell adhesion biomolecules
solution for a period of time. The cell adhesion biomolecules used in these works include
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laminin, collagen, Poly(lysine) etc. Admittedly, this method is easy and has been widely
employed in bionic labs. However, the thickness of the coating and the amount of cell
adhesion biomolecules is hard to control and thus may affect the surface interaction between
the nerve cells and CPs.
Similar to NTFs, modification of cell adhesion cues can be also achieved by electrical
deposition entrapment. However, some evidence showed that entrapment of cell adhesion
laminin peptide together with NGF in PEDOT film decreased the mechanical,
electrochemical and biological performance of CPs films, although the cell adhesion property
was improved [23].
Chemical modification of cell adhesion biomolecules can be achieved by directly binding
intermediate peptide on CPs surface or by general chemical reactions with specifically chosen
dopants. A modification of cell adhesion promoting peptide (GRGDS) on the CPs surface was
made by firstly binding T59, a unique peptide sequence, directly to chloride-doped PPy
(PPyCl) as a bio-functional linker for covalent binding of RGD. The RGD-modified PPyCl
was proved to significantly promote PC12 cell adhesion, while no cell adhesion was seen on
unmodified PPyCl[24]. This method can be applied to immobilize a variety of biomolecules.
Cell adhesion biomolecules can also be attached on the active functional groups of dopant
molecule employed in CPs. A study utilized polyglutamic acid as the dopant for further
modification of the cell adhesion cues polylysine and laminin on PPy surface via standard
amide coupling reactions. Cell adhesion and neurite extension were found to occur in the
micro-patterned area where positive guidance cues were attached (Figure 9)[25].
Wallace’s group recently reported a method using chondroitin sulfate (CS), an extracellular
matrix molecule bearing carboxylic acid moieties, as dopant in electrochemical deposition of
PPy. Type I collagen could be bound on carboxylic acid groups covalently and form a fibrillar
collagen matrix (Figure 10). More PC 12 cells were adhered on PPy substrate due to this
surface modification and neurite outgrowth was also demonstrated, while ES further enhanced
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the ability for nerve regeneration[75, 76]. In this work, the cell adhesion biomolecule did not
serve as dopant, thus would not decrease the physical and chemical properties of CPs.
3.4.3.Incorporation of Other Dopants and Composites
The influence of CPs’ properties on nerve cell response was studied using various dopants
and composites to tune the properties and biocompatibility of CPs. The studies on CPs
dopants covered a wide range of dopant molecules from small molecule (chloride (Cl), pTS,
and nitrite (NO3)), polymer dopants (PSS, PMAS), to biomolecule dopants (CS, HA, heparin
dextran sulfate (DS))[31, 70, 77]. The size and properties of dopants determined the physical,
chemical and interfacial properties of CPs (roughness, modulus, conductivity etc.), which
strongly influenced nerve cell activities. Some biomolecules did not show obvious advantage
in cellular compatibility, which is attributed to the poor CPs substrates it formed. Thus both
biological activity of the dopant and its influence on CPs properties need to be considered
when choosing a CPs scaffold. The aims to synthesize these CPs composites can be classified
into the following categories: increasing biocompatibility, introducing biodegradability, and
introducing elasticity into the CPs scaffold [78].
Generally, natural biomolecules (HA, chitosan) would be selected as dopants when improving
the biocompatibility of CPs is necessary. A PPy/HA composite was fabricated by electrical
deposition of PPy/HA membrane on PPy/PSS substrate. This method retained most of the
conductivity and electrochemical stability of the scaffold while successfully produced a
smooth conductive, HA-containing PPy scaffold. These films retained HA on the surface for
several days in vitro and promoted vascularisation in vivo [79].
Meng et al. chemically synthesized PPy/heparin (PPy/HE) nanoparticles through emulsion
polymerization at different PPy/heparin ratios and added the particles into PLLA chloroform
solution under stirring to generate PPy/PLLA biodegradable membranes of 102 to103 Ω/
square. The existence of HE was verified on the membrane. The conductive membranes
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containing HE-doped PPy particles recorded significantly increased electrical stability,
cell adhesion, and growth [80].
Similar work has been done using chitosan to replace PLLA. 2.5% PPy and 97.5% chitosan
were mixed to form a biodegradable film for Schwann cells ES. The results showed that the
PPy/chitosan membranes supported cell adhesion, spreading, and proliferation with or without
ES. ES applied through the PPy/chitosan composite dramatically enhanced the expression and
secretion of NGF and BDNF when compared with control cells without ES [81].
When biodegradable CPs were needed for in vitro and in vivo applications, copolymerization
of PPy and degradable block poly(ε-caprolactone) (PCL) and poly(ethyl cyanoacrylate)
(PECA) could create biodegradable PPy/PCL and PPy/PECA. The PPy portions of the copolymers permit ES whereas the PCL or PECA blocks enable degradation by hydrolysis. The
studies indicated that these new conductive degradable biomaterials have good
biocompatibility and support proliferation and growth of PC12 cells in vitro (with and without
ES) and neurons in vivo (without ES)[82]. However, the conductivities of the scaffold was
harmed by the copolymerization of degradable blocks.
The improvements of biodegradable CPs scaffold were achieved by coating PPy onto
biodegradable

polymer

scaffolds.

polycaprolactonefumarate

(PCLF)[84],

Various

polymers,

oligo(polyethylene

including

PLGA[83],

glycol)fumarate(OPF)[85]and

poly(D, L-lactide-co-epsilon-caprolactone) (PDLLA/CL)[86] etc., have been employed as
degradable scaffold materials. The coating of PPy showed better cell adhesion ability and can
provide ES to nerve cells and tissues cultured on CPs hybrid scaffolds. Biodegradable
scaffolds obtained from this way got much higher conductivities but low long-term stability
due to the poor adhesion between platform polymers and CPs during degradation process.
This concern was solved by chemical polymerization of monomer with different
concentrations in a biodegradable polymer solution, followed by precipitation. The surface
resistivity of the PPy/PDLLA membrane with 3% PPy was as high as 1 x103 Ω/square. The
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electrical stability was significantly better in the PPy/PDLLA composite than in the PPy
coated polyester fabrics and sustained a biologically meaningful electrical conductivity in a
typical cell culture environment for 1000h [87]. This composite was fabricated into NCs for
further neuroregeneration studies. When PC12 cells are seeded on these NCs and stimulated
with 100 mV for 2 h, there is a marked increase in both the percentage of neurite-bearing cells
and the median neurite length. More importantly, when this PPy/PDLLA conduit was used to
repair a rat sciatic nerve defect it performed similarly to the gold standard autologous graft.
These promising results illustrate the potential that this PPy/PDLLA conducting composite
conduit has for neural tissue engineering[88].
The introduction of elasticity into CPs was mainly realized using silicone. The electrical
properties of the elastomeric conductors were strongly dependent on their composition, and
mixtures were identified that provided high and stable conductivity. In vivo and in vitro
studies for nerve repair demonstrated the feasibility of the use of conductive elastomers for
peripheral nerve stimulating electrodes [89].
By incorporating different kinds of bioactive molecules, the interfacial “release on demand”
delivery of NTFs can be achieved and the properties of CPs can be tuned by carefully
choosing various functional bioactive molecules as dopants, For example, CPs will have
better cell adhesion ability with collagen and laminin, better biocompatibility with HA, HE
and chitosan, better degradability with PCL and PECA, and become stretchable with silicone.
One of the concerns of decoration of biomolucules on CPs is that most of these decorations
affected the conductivity of CPs. These biomolecules dopants did not have π–π coupling
structures and thus harmed the conductivity of CPs. Also, other isolative additives as
biodegradable polymers and silicone affected the interaction between the CPs polymer chains
as well as conductivity. The balance between conductivity and other properties must be
stringently kept to realize the best neuroregeneration effect. Also, new methods like
modifying dopants instead of CPs to avoid conductivity loss should be developed for better
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results. In addition, the dopants of CPs were limited to anions as the polymer chains were
positively charged. Cations and neutral molecules cannot be doped on CPs polymer chains
directly. More specific design and steps were needed which were not good for clinical
applications.
3.5. Interfacial surface guidance of CPs in Neuroregeneration
In general, the strategies for neuroregeneration should address the regrowth of injury neurites,
the plastic remodelling of neuronal circuitry and/or the regeneration of new nerve cells [90].
Therefore, successful scaffold platforms designs should fulfil all needs these three objects
required. For example, axons regrowth requires overcoming an unfavourable and inhibitory
environment, and requires proper axonal spatial organization, target recognition and the
reconstruction of functional synapses. And these requirements can be partially addressed by
designing proper scaffold platform with micro- and nano- structures.
To investigate the influence of the structures and scales of micro- and nanostructured CPs,
various surface topographies including nanofibres, microfibres, nanotubes, micro patterns,
microlines and 3-D structures were fabricated and served as platform scaffold in
neuroregeneration. Techniques that were utilized for CPs scaffold fabrication include
electrospinning, wet spinning, inkjet printing, extrusion printing, electron beam and template
polymerization. Scales of these scaffolds ranged from 100nm to nearly 1mm and influenced
nerve cell performance at various scales. Nerve neurite can grow along both aligned
nanofibres and wet spun microfibres assisted with ES.
3.5.1. CPs Nanofibres scaffolds
The use of nanostructured scaffolds in neuroregeneration is primarily due to their abilities to
promote neuronal adhesion, to recreate an extracellular matrix(ECM) like microenvironment
and to interact with neuronal membranes at the nanoscale[91]. Although it looks like mico- and
nano- structured scaffolds can both impact on tissue/cell surface guidance, such as neurites
outgrowth, orientation and cell immigrations, likely by the bio-mimicry of ECM, the
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mechanism of the interaction of nerve tissues/cells with supporting scaffolds can only occur at
nanoscale level. Firstly, the secretion of neural cell adhesion molecules(NCAM, N-cadherin
and integrins[92]) is sensitive to nanotopography as the adhesion sites on cell membranes are
mainly in the 5-200 nm range. Furthermore, nerve tissues/cells demonstrated a remarkable
preference for the rough surfaces which match the size of themselves (nanofibers, nanotubes
etc.) in neuronal processes including proliferation, neurites growth and orientation[93].
Therefore, nanostructured scaffolds were widely investigated to provide interfacial surface
guidance to nerve tissues/cells.
Electrospinning is the most common used method to generate CPs nanofibres utilized for
nerve tissue engineering platforms to mimic the structural and biological function of native
extracellular matrix as much as possible

[26-28]

. CPs nanofibres can be obtained by

electrospinning CPs blended solutions with other polymers such as gelatine, collagen, poly-Llactide (PLLA)[26, 94] or by chemically coating a CPs layer onto pre-electrospun biopolymer
nanofibres[83, 28].
CPs solutions or dispersions cannot be directly fabricated into nanofibers by electrospinning
due to the concentration and viscosity restrictions. Additional isolative polymers will be
added to tune the rheology of CPs. Molamma P. Prabhakaran et al. has mixed doped PANi
with poly (ε-caprolactone)/gelatin (PG) (70:30) solution for electrospinning to obtain
PANi/PG nanofibres with diameters of 112 ± 8 nm. Nerve stem cell culture was performed on
this scaffold and ES through conductive nanofibrous PANI/PG scaffolds showed enhanced
cell proliferation and neurite outgrowth compared to the PANI/PG scaffolds that were not
subjected to ES [94]. The following work from this group showed that PANI/PLLA electrospun
nanofibres demonstrated a quite similar performance to their previous study [26].
The addition of supporting materials may affect the conductivities of CPs. Another method to
avoid conductivity loss was developed by coating CPs on pre-electrospun biomaterials
nanofibres to create CPs nanofibre structures. The coatings of CPs were often carried out by
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vapour phase chemical polymerization or solution chemical polymerization. In a study of PPy
coated nanofibre, PLGA nano-meshes were firstly fabricated via electrospinning then put in
pyrrole/pTS aqueous solution for chemical polymerization. The reaction was initiated by
FeCl3 and kept for 24 h at 4οC to get PPy/PLGA meshes. The results of cell experiments
showed that PPy/PLGA electrospun meshes enhanced the growth and differentiation of PC12
cells and hippocampal neurons comparable to non-coated PLGA control meshes. ES studies
showed that PC12 cells, exhibited 40–50% longer neurites and 40–90% more neurite
formation compared to unstimulated cells on the same scaffolds [83].
While random CPs nanofibres showed promotion effect in nerve neurite outgrowth, the effect
of aligned nanofibre on neurite extension guidance was studied by a group using vapour phase
coated PPy on highly aligned nanofibres. Poly(styrene-b-isobutylene-b-sty-rene) (SIBS) and
FepTS have been electrospun onto a gold coated mylar sheet in a sealed box containing
pyrrole monomer vapour. PPy was polymerized on highly aligned SIBS/FepTS nanofibres via
vapour phase polymerization during the electrospinning process. Cell experiments illustrated
that neurite outgrowth from PC12 cells could be highly orientated parallel to the aligned
PPy/SIBS fibres. Physical interactions between the nerve cells and PPy/SIBS fibres were
observed using atomic force microscopy (Figure 11). These observations indicated a role of
contact guidance as a mechanism for the observed alignment [28].
Besides PANi and PPy, PEDOT electrospun nanofibres have also been investigated as nerve
tissue engineering scaffolds. Electrospun PET nanofibres were coated with PEDOT/pTS using
vapour phase polymerization. The nanofibres were good platforms for providing cells with a
substrate for adhesion and proliferation. These conductive scaffolds were used to electrically
stimulate Ca2+ signaling

[36, 95]

in SH-SY5Y nueroblastoma cells. Results showed that the

combination of ES with highly porous and permeable 3D structures provided additional
functionality to stimulate cells or record cell signaling [96].
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The increasing demands for combined and complicated interfacial stimulation promoted the
incorporation of more functional molecules into nanofibres scaffold. Based on the PPy coated
PLGA nanomesh discussed above [83], NGF was chemically immobilized onto the surface of
the fibres (Figure 12). These NGF immobilized PPy coated PLGA (NGF/PPy/PLGA) fibres
supported PC12 neurite formation (28 ± 3 % of the cells) and neurite outgrowth (14.2 μm
median length), which were comparable to that observed with NGF (50 ng/mL) in culture
medium (29 ±1.3 %, 14.4 μm). ES of PC12 cells on NGF immobilized PPy/PLGA fibre
scaffolds was found to further improve neurite development and neurite length by 18% and
17%, respectively, compared to unstimulated cells on the NGF immobilized fibres. Hence,
sub-micrometre-scale fibrous scaffolds that incorporate neurotrophic and electroconductive
activities may serve as promising neural tissue engineering scaffolds; such as nerve
guidance conduits[27].
3.5.2. CPs Nanotubes
Another type of nanostructured CPs scaffold, CPs nanotubes, were designed by Abidian et al.
to increase charge capacity density (CCD) for stronger and longer ES to nerve cells and
decrease impedance for better neural signal recording. The hollow structure of nanotubes
creates more surface areas compared to nanofibres, as well as films, allowing more surfaces
for electrical charges storage[97], which means high capacitance as well as CCD. The
impedance of the CPs can be represented by the equation:
Z = R + I (ωL - 1/ωC)

(1)

Where R is resistance, I is current, L is inductance, C is capacitance and ω is a sinusoidal
undulation frequency[98]. Therefore, higher capacitance will lead to lower impedance from this
equation. The PEDOT and PPy nanotubes were created via electrical deposition of CPs on
pre-electrospun PLA nanofibres followed by removal of the PLA template by dissolving them
in dichloromethane. Electrochemistry studies on impedance and charge capacity density
(CCD) illustrated that PPy and PEDOT nanotubes have lower impedance and higher CCD in
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comparison with their film counterparts. DRG cultured on CPs nanotubes exhibited longer
neurites length than their film comparison samples. In addition, CPs nanotubes showed long
term electrochemical stability in CV characterization, illustrating that it can serve as scaffolds
in long term cell culture and ES experiments [99].
3.5.3. CPs Nanoporous Scaffold
The exploitation of nanostructured conductive polymers, is hampered by their low solubility,
poor mechanical integrity, and difficulty in fabrication. To improve the mechanical strength
and retain the nanostructures, Cai et al. prepared electrically conductive nanoporous materials
by coating nanoporous cellulose gels (NCG) with PPy. The resulting NCG/PPy composite
hydrogels were converted to aerogels by drying with supercritical CO2, giving a density of
0.41 - 0.53 g cm-3, nitrogen adsorption surface areas of 264 - 303 m2 g-1, and high mechanical
strength. In vitro studies showed that the incorporation of PPy into an NCG enhances the
adhesion and proliferation of PC12 cells. ES demonstrated that PC12 cells attached and
extended longer neurites when cultured on NCG/PPy composite gels with DBSA dopant[100].
3.5.4. CPs Microfibres Scaffold
Besides, nanostructures, significant efforts have also been put into the development of
electroactive hybrid scaffolds at the micrometre scale for the guidance of nerve cell migration
and neurite outgrowth at certain directions. Nanostructures can create different surface
morphologies and surface roughness to influence the cells at the nanometre scale while the
micro-scale scaffold is comparable to a cell body size for the whole cell to attach and migrate
along the scaffold.
Wet spinning microfibres conductive scaffold has been studied for its potential to control the
multiple cues, such as topographic guidance, support, and ES to promote neurite directional
growth. Biodegradable copolymer PLA:PLGA (75:25) was wet-spun into fibres
(approximately 30 μm in diameter), and aligned onto gold-coated mylar wrapped around a
collector spool. The constructs were laid flat to facilitate the galvanostatic deposition of
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PPy/pTS film, creating a thin layer of PPy/pTS between the biodegradable fibres. Scanning
electron microscopy (SEM) confirmed the presence of the fibres embedded in the CPs layer
(Figure 13 A-C). Dorsal root ganglia (DRG) explants cultured on this scaffold demonstrated
axonal growth and Schwann cell migration followed the path of the polymer fibres on both
stimulated and unstimulated platforms (Figure 13 E-G). ES enhanced the axonal growth
significantly over 60% and promoted Schwann cell migration to some extent as well [18].
Another study on the micrometre scale fibre scaffold utilized a blend of electrically
conductive PANi and polypropylene (PP) composite fibres as the backbone of encapsulated
nerve tissue engineering relays. Fibres with around 400 μm diameter were manufactured by
extrusion through a capillary rheometer and coated with collagen for DRG culture. A high
density of neurons on the fibre surface (over 700 neurons/mm2) was obtained and resulted in
robust neurite extension and network formation. After that, this neuron network on fibre
surface was encapsulated with agarose to form a protective barrier while potentially
facilitating network stability (Figure 14). These efforts effectively created functional
electrical interfaces for nerve cells and improved neurocompatibility, high density nerve cell
adhesion and neurite network formation on micrometre scale fibre surfaces [19].
3.5.5.CPs Micro Patterns
To combine the electrical and topographical cues for the stimulation of nerve cells, 2-D CPs
micro-patterns have also been developed to function as tissue engineering scaffolds. Gomez et
al created 1 and 2 μm wide PPy micro channels using electron-beam (e-beam) lithography
and electrical polymerization. Embryonic hippocampal neurons cultured on patterned PPy
polarized (i.e., defined an axon) faster on the modified material, with a two-fold increase in
the number of cells with axons compared to cells cultured on unmodified PPy (Figure 15).
These topographical features also have an effect on axon orientation but do not have a
significant effect on overall axon length [20].
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Micro-patterns can also be created by inkjet printing. Parallel PPy lines (100μm width) have
been deposited on biocompatible polymer substrate then covered by collagen using a Dimatix
inkjet printer. PC 12 cells cultured on the substrate could be located on the surface of the
micro lines and formed a neurite network. ES applied at the ends of the line can promote
neurite outgrowth and guide the orientation of neurite extension along the printed PPy lines
[21]

.

3.5.6. 3D CPs Nerve Conduits
To guide nerve tissues/cells recovery at lesion gaps, 3D PPy tubes were made via electrical
deposition of PPy on wire template with different diameters. After the growth of PPy film, a
reduction potential applied to the template allowed mechanical dissociation from the electrode
template, creating a stand-alone PPy tube. Multichannel tubes were also fabricated via the
same method. The obtained PPy nerve conduits were cut into 15mm lengths and placed in
transected rat sciatic nerves, and were shown to support nerve regeneration over an 8-week
time period[101].
In summary, due to their inherent electrical conductive properties, reversible electrochemical
properties, interfacial properties and their cyto-compatibility, CPs successfully provided all
kinds of interfacial stimulations discussed above

[22, 102]

. In detail, firstly CPs’ highly

conjugated carbon backbone and charge transfer ability allow them to provide direct ES to
nerve tissues/cells cultured on their surface to significantly enhance neurite outgrowth;
secondly, CPs can be doped with positively charged biomolecules and proteins for surface
modification purposes which can improve cell adhesion properties and cell proliferation
abilities; thirdly, CPs exhibit reversible electrochemical properties to allow the dopants to be
released from the polymer chains, which illustrate the possibility of “release on demand”
interfacial NTFs delivery in neuroregeneration; finally, their processability allow them to be
formed into various geometries or patterns to get additional interfacial properties. Recent
developments in micro- and nano-scale fabrication techniques of CPs, including laser beam,
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electrospinning, wet spinning, and inkjet printing, create a series of nanofibres, nanotubes and
micro dots and lines arrays to promote interaction between neural cells/tissues and materials
surface.
The combined interfacial stimulations that CPs can provide made the foreground of CPs
scaffolds in neuroregeneration quite promising. However, the barrier of transferring CPs into
clinical ues from laboratory still existed. First of all, the electrochemical stabilities of CPs
were not as reliable as needed which may result in the failures in interfacial NTFs delivery
and ES. Environments including temperature, pH values, salts in tissue/cell culture mediums
can all influence the electrochemical stabilities of CPs. The possible loss of dopants and
fracture of polymer chains during ES may change the conductivity of the scaffold, which may
lead to lower stimulation current and weak stimulation effects under the same potentials
applied. The impendence of CPs would also increase for the same reasons and affected ES
results or the signal recording results. To avoid this, ES of CPs should be applied in an
appropriate range to make sure that CPs scaffolds were not overloaded under ES. The
biodegradability of CPs would be another issue that did not achieve the standard of clinical
utilization. CPs themselves were not degradable at all. Biodegradable CPs were most often
created by coating CPs upon biodegradable polymers such as PLGA. The CPs layer broke
into small pieces with PLGA degradation and the influence of these CPs residues remains
unknown in vivo, which limited the applications of CPs in clinical application. In addition, a
great many of CPs devices for neuroregeneration were fabricated via electrochemical
methods, which is not suitable for massive production, limited the utilization of CPs in
clinical as well.
3.6.

Bio-interface

of

Carbon

nanotube

and

Graphene

based

materials

in

Neuroregeneration
Graphitic nanomaterials, such as carbon nanotubes (CNTs) and graphene, have gained a great
deal of interests in the scientific communities due to their novel properties and wide range of
28

potential applications. As these graphitic materials hold similar but enhanced electrochemical
properties in comparison with CPs, we also discuss the bio-interface effects in
neuroregeneration that employed CNTs and Graphene based materials in this review.
Several early studies demonstrated CNTs were capable of serving as the scaffold in nerve
tissue engineering and can offer ES to nerve cells that are cultured on the CNTs’ surface
[103]

.Recent study on the cytotoxicity of CNTs and graphene illustrated that graphene is a

better choice in nerve regeneration as it had lower cytotoxicity and better physical properties
valued by PC 12 cells than single wall CNTs [104]. The promotion of nerve stimulation by a
graphene substrate was studied using a mouse hippocampal culture model by Li et al.. The
results revealed that graphene substrates exhibited excellent biocompatibility, as cell viability
and morphology were not affected in comparison with the control specimen. In addition,
neurite numbers and average neurite length on graphene were significantly enhanced during
2-7 days after cell seeding compared to tissue culture polystyrene (TCP) substrates [105].
A 3-D graphene foam electrode has been recently reported as a promising candidate for nerve
stem cell scaffold as it may incorporate topographical, chemical and electrical cues in the
same scaffold to provide an environment for neural tissue regeneration that is superior to
conventional inert biomaterials (Figure 16). It was found that three-dimensional graphene
foams (3D-GF) can not only support NSCs growth, but also keep cells at an active
proliferation state with regulation of Ki67 expression than that of two-dimensional graphene
films. Meanwhile, phenotypic analysis indicated that 3D-GFs can enhance the NSCs
differentiation towards astrocytes and especially neurons [106].
In addition, CNTs and graphene based materials can enhance the properties of CPs in
CPs/graphitic materials hybrid scaffold. CNT doped PEDOT showed an enhancement in
electrical stability and conductivity compared to PEDOT, while neuron cellular activities
were more or less the same

[107]

.

PPy/graphene oxide (GO) composites demonstrated
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significantly lower impedance than Pt electrode and pure PPy when used as neural probes
materials [108].
4. Summary and Criteria
The importance of bio-interface of polymer based biomaterials in neuroregeneration was
proven by a series of investigations despite the existence of weakness and imperfection. To
better clarify what kinds of criteria that an ideal biocompatible polymers interface should
achieve, the advantages and disadvantages of current developed polymer scaffolds discussed
above are summarized in Table 2.
We can easily conclude from Table 2 what are the properties that a successful biocompatible
polymer scaffold should possess (Table 3).

These biocompatible polymers should be

biocompatible, biodegradable to ensure their long term clinical usage. In addition, these
polymers should have specific physical, electrical, interfacial and biological properties to
serve stably in a cell culture environment, provide interfacial ES, and interfacial delivery of
NTFs to a lesion site when necessary. These criteria should be achieved by careful design and
synthesis of the polymer scaffold which can successfully mimic an in vivo microenvironment, which is composed of cells, support scaffolds, growth factors and the
extracellular matrix, and plays an important role in regulating neurogenesis, survival and
regeneration of nerve cells [109].
Flaws exist in nearly all current techniques more or less; such as synthetic biodegradable
polymers’ poor cell attachment ability and uncertain long term stability of CPs. The direction
for future development of bio-interfaces of polymer based materials in our expectations is to
address the criteria we concluded in Table 2 in a single scaffold; as many as possible. To
achieve this target, tuning polymer properties using hybrid scaffold with multiple
modification methods should be considered. For example, a novel scaffold like cell adhesion
hydrogel coated NTFs modified CPs microfibres can combine ES, cell attachment ability and
NTF delivery together for a complicated stimulation to nerve cells and tissues.
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5. Perspectives
Success gained till now in the bio-interface of biocompatible polymers for neuroregeneration
does not mean that the application of novel biocompatible polymer scaffolds clinically is just
around the corner. Actually, some doubts still exist concerning this kind of material. For
example, an often used method to create a biodegradable CPs scaffold is the coating of CPs
on the outer surface of a biodegradable polymer such as PLGA. However, nobody has
investigated about what happens after the CPs disintegrate with PLGA degradation; ie how
will these small CPs pieces be discarded and excreted, in in vivo experiments. Also, whether
these CPs pieces are completely unharmful to the human body is still in doubt. Another
concern for CPs scaffolds in clinical use is their long-term stability, including both chemical
stability in vivo and electrical stability to maintain ES for long period implantation. In
addition, whether long term implantation of the CPs scaffold will result in rejection by the
body has no conclusion either.
Thus we assume that in the recent future, investigations on the bio-interface of biocompatible
polymer scaffolds will focus on the resolution of these problems to bridge the gaps between
lab research activity and clinical application. In particular, the reliability of biomaterials in
neuroregeneration needs to be evaluated more intensively before medical applications. The
evaluation is not only to study the direct responses from animals but also to build reliable
models for analysis, thus offering greater knowledge to rationally improve and/or redesign
biomaterials. Composing novel engineered nanostructures or nanomaterials to enhance
multifunctionality and/or reliability is another aspect that should be valued. Materials design
and exploration is the key method to solve the problems that exist concerning
biocompatibility/ biodegradability. More attention will be paid to long term in vivo
compatibility testing of novel scaffolds, and the possibility of scalable massive commercial
production of polymer scaffolds. The translation of research output to commercial therapy
products will be the first priority in all.
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Figure 1. The growth of NSCs on the HA hydrogel composite for 5 days. (a, b) The
fluorescent staining of nestin showed the NSCs (green) adhered on the gel, grew well and
spread widely along the wall of the scaffold (a overall view), extending long neurites (b, high
magnification). (c) The hydrogel showed good biocompatibility and support for NSCs by
SEM. (d) The proliferation array by CCK-8 showed the NSCs grew faster on the hydrogel
composite than on the HA hydrogel control (*p<0.05)[29].
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Figure 2. A) Micrograph of a typical NC (10 x magnification). B) Micrographs of crosssections of NC in the dry state and after swelling to equilibrium (20 x magnification)[53].

Figure 3. (a) Scanning electron micrograph of the nerve conduit which consists of a PGA–
collagen tube filled with collagen sponge; (b) Suture methods and intraoperative view after
implantation of a PGA–collagen tube[54].
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(a)

(b)

(c)
Figure 4. Chemical structures of (a) PANi; (b) PPy and (c)PEDOT-PSS
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Figure 5. PC 12 cell differentiation on polypyrrole without (A) and with (B) application of an
electric potential. Bar = 100 μm[22].
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Figure 6. Representative images of cochlear neural explants grown on PPy/pTS polymers
with and without neurotrophin. Neurites were visualised by immunocytochemistry with a
neurofilament-200 primary antibody and a fluorescent secondary antibody (green). Cell nuclei
are labelled with DAPI (blue). In the absence of neurotrophin (PPy/pTS), very few neurites
were observed from explants, while explants grown on PPy/pTS containing neurotrophin
demonstrated increased numbers of sprouting neurites. A greater number of neurites per
explant were observed on explants grown on the electrically stimulated PPy films (right).
These images were taken after 4 days of explants culture. Scale bar is 200 µm and the same
for all images[69].
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Figure 7. Scheme of the NGF immobilization process. PAA was conjugated to an azido
compound (PAA-azido). This conjugate was cast twice on PPy, followed by casting of NGF.
UV light exposure promoted the formation of covalent bonds via the azido groups,
immobilizing NGF to PPy[73].

Figure 8. (a) Schematic of the pyrrole-NSE synthesis (3). 1-(2-Cyanoethyl)pyrrole (1) was
converted to 1-(2-carboxyethyl)pyrrole (2), followed by the NHS substitution at the carboxyl
group. (b) Electrochemical synthesis of the copolymers of pyrrole and pyrrole-NSE in
acetonitrile with tetrabutylammonium perchlorate (TBA-ClO4) as the dopant. PPy/NSEx
indicates the copolymer which is synthesized with x mol% of pyrrole-NSE from a 50 mM
total monomer concentration in the polymerizing solution [74].
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Figure 9. Phase contrast and fluorescent images of DRG adhered to a surface of PPy[pGlu]–
X where X=(a) pLys, (b) Lmn and (c) pLys–Lmn. The cells were fixed at 2 days (a and c) or
at 12 days (b) after plating. Neurites stained positive for GAP-43 (green fluorescence). Cell
nuclei were labelled with DAPI (blue fluorescence). All images were taken at 10×
magnification and thus, the 200 μm scale bar in (b) applies to all images shown[25].
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Figure 10. AFM micrographs of PPy/CS/Col film (A), amplified area on PPy/CS/Col film
without collagen fibers (B) and pristine PPy/CS film (C) in PBS. Blue arrow-large fibrous
structure; Black arrow - smaller individual fibres[76].
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Figure 11. (A) Optical and (B) corresponding AFM images of the boxed region in (A)
showing a neurite (arrows) extending along a PPy/SIBS fibre (black asterisks). Scale bar in (A)
= 20 μm. Scale bar in (B) = 5 μm. (C) High-resolution AFM image showing small finger-like
lateral outgrowths (arrows) making contact with a PPy/SIBS fibre (black asterisks). Scale bar
in (C) = 1 μm[28].
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Figure 12. A. NGF/PPy/PLGA provides multiple cues for neurite outgrowth as the scaffolds
deliver submicrometer-scale fibrous features, electrical conductivity, and neurotrophic
activity. B. Schematic for fabricating NGF immobilized PPy/PLGA fibers (NGF/PPy/PLGA).
i) Electrospun PLGA nanofibers were coated with PPy and PPy(COOH), producing
PPy(COOH)/PLGA. ii) NGF (represented as circles) was chemically immobilized onto
PPy(COOH)/PLGA[27].
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Figure 13. SEM images (A–C) reveal a relatively smooth PPy surface, in which PLA: PLGA
fibers are embedded. Tissue culture chambers were attached to the scaffold surface to
facilitate DRG growth and stimulation (D). Axon growth (arrows) and Schwann cell (arrow
heads) migration is observed on both the biodegradable fibers (E and F) and the PPy/pTS
surface (G). Fluorescent microscopy images (E–G) demonstrate that axonal growth and
Schwann cell migration follow the path of the embedded polymer fibers on both stimulated
and unstimulated scaffolds. Scale bars = 100 μm (A), 20 μm (B), 5 μm (C), and 50 μm (E–
G)[18].
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Figure 14. Tissue-engineered neural-electrical relays. Small diameter (<400 μm) electrically
conducting PA–PP fibers were chosen as the electrical interface due to their mechanical
compliance and tailored conductive properties (a). PANi–PP fibers were processed to permit
neuronal growth and network formation directly on the fibers (b). Then, these biohybridized
neural-conductive fibers were encapsulated with a bio-inert hydrogel to form a protective
barrier while potentially stabilizing the network in intimate contact with the PANi–PP (c). A
multitude of relays may be used in parallel to create complex interface microsystems, with the
alternate end of the PANi–PP fiber projecting to a processing device for signal filtering,
amplification and output (d). These ‘wet’ biohybrid neural interface systems may be used as
investigative platforms in vitro or as biohybrid relays in vivo[19].
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Figure 15. From left to right: phase-contrast, fluorescence, and SEM microscopy images, of
hippocampal neurons on PPy. A–C) Cells cultured on 2 μm wide and 200 μm deep
PPymicrochannels; D–F) cells cultured on unmodified PPy. The green labelling (Alexa 488)
corresponds to Tau-1 (axonal marker) immunostaining. Cells polarized more readily on
microchannels than on unmodified PPy. The scale bar is 20μm (A, B, D, E) and 5μm (C, F)[20].
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Figure 16. NSCs adhesion and proliferation on 3D-GF scaffold. Low- (a) and high- (b)
magnified SEM images of NSCs cultured on 3D-GFs under the proliferation medium. The
inset illustrates the interaction between the cell filopodia and 3D-GF surface. (c) Cell viability
assay of NSCs on 3D- GFs after 5 days of culture as determined by live/dead assay, live cells
are stained green and dead cells are red, white arrow points to dead cell. The lower right inset
depicts the percentage of live cell on 2D graphene films and 3D-GFs. (d) Fluorescence images
of NSCs proliferated on 3D-GFs for 5 days, immunostaining markers were nestin (green) for
neural stem cells and DAPI (blue) for nuclei. (e) NSCs were double-immunostained with antiKi67 (red) and anti-nestin (green) antibodies, Ki67 is a marker for cell proliferation. (f)
Western Blot analysis of Ki67 expression on 2D graphene films and 3D-GFs. The Data are
presented as mean ± standard error (s. e. m.), *p < 0.05, **p< 0.01[106].
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Table 1. Most widely studied materials for nerve conduit with related properties and selected
studies where they were used[44].
NC polymers

Characteristics

Silicone:poly(dimethylsiloxane)
PGA: poly(glycolide)
PHB: poly(3-hydroxybutyrate)
PLA: poly(L-lactide) acid
PLGA:poly(DL-lactide)co-glycolide
Chitosan:b-(1-4)-linked D-glucosamine
PHEMA-MMA:poly(2-hydroxyethyl
methacrylate-co-methyl methacrylate)
Polyester urethane

References

Highly elastomeric polymer, non-biodegradable, bioinert,
impermeable, hydrophobic
Aliphatic polyester, biodegradable by hydrolysis, Commercial NC
approved by FDA
Aliphatic polyester, biodegradable by hydrolysis
Aliphatic polyester, very slowly biodegradable
by hydrolysis
Aliphatic polyester, slowly biodegradable
by hydrolysis
Polysaccharide, enzymatically degradable
Hydrogel-forming polymer, nonbiodegradable,
stiffness in the range of nerve tissue
Elastomeric polymer, biodegradable

[45, 48]
[34]
[49]
[35]
[29, 50]
[50]
[51]
[52]

Table 2. Summary of advantages and disadvantages of biocompatible polymer scaffolds.
Polymer scaffolds

Advantages

Disadvantages

Biodegradable polymers

Biocompatible;
Biodegradable;
Processable ;

Not conductive

Controllable structure;
Controllable release period;

Hydrophobic;
Poor cell attachment ability;
Harsh preparation conditions;
Harmful to NTFs during preparation.

Synthetic
polymers

biodegradable

Natural
polymers

biodegradable

Biodegradable
polymers

CPs
Electrochemically
deposited
CPs
Chemically polymerized

Graphitic materials

Gentle
preparation
conditions;
Not harmful to NTFs.
Good cell attachment ability
Conductive;
Low impendence;
Good cell attachment ability.
Fast
and
one
step
polymerization;
Less excessive by-products;
Support scalable fabrication;
Highly processable;
Can be fabricated into
multiple structures
Nanostructures
Highly conductive
Electrochemical stability

Burst release of NTFs in initial stage.

Non-degradable
Poor long term stability
Scale limitation;
Dimension limitation.
Time and efforts consuming compared to
electrodeposited CPs film;
Excessive reactants and by-products may
still exist.
Long term cyto compatibility in doubt.

Table 3. Criteria for ideal biocompatible polymer scaffolds.
Properties

Criteria

Biocompatibility

Compatible with neuron cells and in vivo environment
Ability to decompose in both in vitro and in vivo environments
Decomposition products not harmful
Stability in cell culture environment;
Ability for nanoscale and microscale fabrication to generate topographical stimulation;
Low hardness.
High conductivity;
Low impendence;
Electrochemical stability;
Good cell attachment and guidance ability;
Ability to deliver NTFs;
Ability to promote cell proliferation and neurite outgrowth.

Biodegradability
Physical Interface

Electrical Interface

Biological Interface
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This paper reviews the studies in the bio-interface of polymer based materials for
neuroregeneration, discussing various interfacial stimulation methods (interfacial NTFs
delivery, surface guidance, electrical stimulation and molecules decoration) that biopolymers
can provide to lesion neural cells/tissues, and proposes the criteria and perspective of biointerface of polymer for neuroregeneration for future development.
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